|
13:30 RNA world: the story of noncoding RNAs and their application in
cardiovascular diseases
Malakootian M. (Iran) |
|||
|
13:45 The importance of non-coding RNAs in clinics
Mowla SJ. (Iran) |
|||
|
14:00 Non coding RNAs and Cardiac fibrosis
Soltani B. (Iran) |
|||
|
14:15 Role of genetic testing in Hypercoagulable state
Sadeghipour P. (Iran) |
|||
|
14:30 The interplay between DNA and RNA variants in premature CAD
susceptibility; focusing in ANRIL lncRNA
Taheri E. (Iran) |
|||
|
14:45 Upregulation of miR-182-5p and miR-9-5p and downregulation of
Talin-1 in coronary artery disease as novel biomarkers
Gholipour A. (Iran) |
